![]() |
|
|||
|
June 1 (Bloomberg) -- Amgen Inc.s bone-strengthening drug denosumab, the focus of the largest development program in the companys history, was cleared by U.S. regulators for use in postmenopausal women with osteoporosis.
|
| Thread Tools | |
| Display Modes | |
|
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Sanofi CEO Sees Stunning Results for Cancer Drug (Update2) | cancerfr | Extracranial Germ Cell Tumor | 0 | 06-07-2010 07:43 PM |
| Amgens Bone Drug Enters Competitive U.S. Osteoporosis Market | cancerfr | Bone Cancer | 0 | 06-02-2010 04:30 PM |
| Amgens Bone Drug Cleared by U.S. for Osteoporosis (Update1) | cancerfr | Bone Cancer | 0 | 06-02-2010 04:30 PM |
| GTx Prostate Cancer Drug Fails to Provide Benefit (Update2) | cancerfr | Bone Cancer | 0 | 05-26-2010 05:14 PM |
| Novartis, Orions Stalevo Drug May Have Cancer Risk (Update2) | cancerfr | Latest Cancer News | 0 | 04-01-2010 10:36 AM |